http://bio2rdf.org/drugbank_resource:DB00176_DB00382_nanopub.RArIzrJVaGFpoVlFn7_bIcslBAmF-OKh_oyh2vPGYML5I#head http://bio2rdf.org/drugbank_resource:DB00176_DB00382_nanopub.RArIzrJVaGFpoVlFn7_bIcslBAmF-OKh_oyh2vPGYML5I http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00176_DB00382_nanopub.RArIzrJVaGFpoVlFn7_bIcslBAmF-OKh_oyh2vPGYML5I#assertion http://bio2rdf.org/drugbank_resource:DB00176_DB00382_nanopub.RArIzrJVaGFpoVlFn7_bIcslBAmF-OKh_oyh2vPGYML5I http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00176_DB00382_nanopub.RArIzrJVaGFpoVlFn7_bIcslBAmF-OKh_oyh2vPGYML5I#provenance http://bio2rdf.org/drugbank_resource:DB00176_DB00382_nanopub.RArIzrJVaGFpoVlFn7_bIcslBAmF-OKh_oyh2vPGYML5I http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00176_DB00382_nanopub.RArIzrJVaGFpoVlFn7_bIcslBAmF-OKh_oyh2vPGYML5I#publicationInfo http://bio2rdf.org/drugbank_resource:DB00176_DB00382_nanopub.RArIzrJVaGFpoVlFn7_bIcslBAmF-OKh_oyh2vPGYML5I http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00176_DB00382_nanopub.RArIzrJVaGFpoVlFn7_bIcslBAmF-OKh_oyh2vPGYML5I#assertion http://bio2rdf.org/drugbank:DB00176 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00176_DB00382 http://bio2rdf.org/drugbank:DB00382 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00176_DB00382 http://bio2rdf.org/drugbank_resource:DB00176_DB00382 http://purl.org/dc/terms/identifier drugbank_resource:DB00176_DB00382 http://bio2rdf.org/drugbank_resource:DB00176_DB00382 http://purl.org/dc/terms/title DDI between Fluvoxamine and Tacrine - Fluvoxamine, a strong CYP1A2 inhibitor, may decrease the metabolism and clearance of tacrine, a CYP1A2 substrate. Concomitant therapy should be avoided as it could lead to severe toxic effects such as hepatotoxicity. If concomitant therapy is used, monitor for altered efficacy and toxic effects, such as gastrointestinal and hepatic effects, of tacrine. http://bio2rdf.org/drugbank_resource:DB00176_DB00382 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00176_DB00382 http://www.w3.org/2000/01/rdf-schema#label DDI between Fluvoxamine and Tacrine - Fluvoxamine, a strong CYP1A2 inhibitor, may decrease the metabolism and clearance of tacrine, a CYP1A2 substrate. Concomitant therapy should be avoided as it could lead to severe toxic effects such as hepatotoxicity. If concomitant therapy is used, monitor for altered efficacy and toxic effects, such as gastrointestinal and hepatic effects, of tacrine. [drugbank_resource:DB00176_DB00382] http://bio2rdf.org/drugbank_resource:DB00176_DB00382_nanopub.RArIzrJVaGFpoVlFn7_bIcslBAmF-OKh_oyh2vPGYML5I#provenance http://bio2rdf.org/drugbank_resource:DB00176_DB00382_nanopub.RArIzrJVaGFpoVlFn7_bIcslBAmF-OKh_oyh2vPGYML5I#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00176_DB00382_nanopub.RArIzrJVaGFpoVlFn7_bIcslBAmF-OKh_oyh2vPGYML5I#publicationInfo http://bio2rdf.org/drugbank_resource:DB00176_DB00382_nanopub.RArIzrJVaGFpoVlFn7_bIcslBAmF-OKh_oyh2vPGYML5I#signature.MCwCFHQIYM8zc-YN http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00176_DB00382_nanopub.RArIzrJVaGFpoVlFn7_bIcslBAmF-OKh_oyh2vPGYML5I#signature.MCwCFHQIYM8zc-YN http://purl.org/nanopub/x/hasSignature MCwCFHQIYM8zc+YNsxlvhVIbqNRGEfcpAhR6JKFMqsjHy/VKa/ubvD2/wMGShA== http://bio2rdf.org/drugbank_resource:DB00176_DB00382_nanopub.RArIzrJVaGFpoVlFn7_bIcslBAmF-OKh_oyh2vPGYML5I#signature.MCwCFHQIYM8zc-YN http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00176_DB00382_nanopub.RArIzrJVaGFpoVlFn7_bIcslBAmF-OKh_oyh2vPGYML5I http://purl.org/dc/terms/created 2018-03-30T11:13:12.623+02:00 http://bio2rdf.org/drugbank_resource:DB00176_DB00382_nanopub.RArIzrJVaGFpoVlFn7_bIcslBAmF-OKh_oyh2vPGYML5I http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00176_DB00382_nanopub.RArIzrJVaGFpoVlFn7_bIcslBAmF-OKh_oyh2vPGYML5I http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00176_DB00382_nanopub.RArIzrJVaGFpoVlFn7_bIcslBAmF-OKh_oyh2vPGYML5I#signature.MCwCFHQIYM8zc-YN http://bio2rdf.org/drugbank_resource:DB00176_DB00382_nanopub.RArIzrJVaGFpoVlFn7_bIcslBAmF-OKh_oyh2vPGYML5I http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234